GN

Gollahalli Nageswara Phani Raj

Director Director DIN 06363861
DIN 06363861 First appointment Oct 1998 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Oct 1998
Shareholding value β€’β€’β€’β€’ Premium profile

About Gollahalli Nageswara Phani Raj

Data last updated:

Gollahalli Nageswara Phani Raj was a Director at Ramakrishna Homeo Pharmaceuticals Private Limited (1998–2012). The company operates in Healthcare.

DIN 06363861
Primary Designation Director
Industry Healthcare
First Appointment 25 Oct 1998

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Oct 19981991₹98.6 Lakh (FY 2023)Dissolved Under Section 54

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ramakrishna Homeo Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gollahalli Nageswara Phani Raj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gollahalli Nageswara Phani Raj

Gollahalli Nageswara Phani Raj was first appointed on 25 Oct 1998 as Director at Ramakrishna Homeo Pharmaceuticals Private Limited.

Gollahalli Nageswara Phani Raj held 1 earlier board appointment: Ramakrishna Homeo Pharmaceuticals Private Limited (Director, 25 Oct 1998 to 01 Aug 2012).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available